Summary
This 8-K filing from WellPoint, Inc. (now Elevance Health, Inc.) on August 29, 2012, announces significant leadership changes. The company is actively searching for a new President and Chief Executive Officer to succeed Angela F. Braly, who has departed from her roles as CEO, President, Chair, and Board member by mutual agreement. Ms. Braly will remain employed through December 31, 2012, and will receive severance compensation and benefits as per her agreement. In the interim, John Cannon has been appointed Interim President and CEO. Jackie M. Ward has taken on the role of Non-Executive Chair of the Board. These changes signal a transition period for the company, with the Board of Directors actively seeking a permanent successor to lead WellPoint through its strategic initiatives and future growth.
Key Highlights
- 1Departure of Angela F. Braly as President and CEO, effective August 28, 2012.
- 2WellPoint, Inc. has initiated a search for a new President and CEO, considering both internal and external candidates.
- 3John Cannon appointed as Interim President and CEO.
- 4Jackie M. Ward named Non-Executive Chair of the Board of Directors.
- 5Ms. Braly will remain employed by the company until December 31, 2012, under a separation agreement.
- 6Ms. Braly to receive severance compensation and benefits, with vested stock options remaining exercisable.
- 7The Board of Directors has established a search committee to facilitate the CEO selection process.